Tag: ablation
Medtronic mapping and ablation system shows “safety and performance” in treating...
Medtronic have announced the 12-month findings that supported the Affera Mapping and Ablation system CE Mark, demonstrating that the Sphere-9 catheter can successfully treat...
EHRA 2023: Novel ablation strategy increases freedom from arrhythmia in AF...
An innovative three-step ablation approach including ethanol infusion of the vein of Marshall improves freedom from arrhythmias in patients with persistent atrial fibrillation (AF)...
Analysis of NIS database shows racial disparities in atrial fibrillation outcomes...
Using data from a large and “nationally representative” sample of the US population, a recent study is the first—the authors posit—to demonstrate racial differences...
Ablation as first-line treatment cuts AF progression compared to antiarrhythmic drugs
Ablation as a first-line treatment for atrial fibrillation (AF) disease is associated with significantly better clinical outcomes than starting with antiarrhythmic drugs.
These were the...
AF Symposium 2022: Lower pulmonary vein to left atrium volume ratio...
Pulmonary vein-left atrial (PV/LA) volume ratio is a significantly better predictor power for atrial fibrillation (AF) recurrence than LA dimension in patients with normal...
AF Symposium 2022: Latest evidence for lattice tip catheter ablation strategies...
Pulsed-field ablation (PFA) and/or radiofrequency ablation (RFA) using a lattice-tip catheter can both isolate pulmonary veins (PVs) and create linear lesions efficiently and safely,...
Same-day discharge for catheter ablation of atrial fibrillation deemed safe and...
A recent systematic review and meta-analysis, published in the Journal of Interventional Cardiac Electrophysiology, has deemed same-day discharge following catheter ablation of atrial fibrillation...
Hot balloon ablation and cryoballoon ablation deemed effective for AF treatment
Both cryoballoon ablation (CBA) and hot balloon ablation (HBA) are effective treatment options for atrial fibrillation (AF), however, patients treated with HBA are more...
Boston Scientific launches its DirectSense technology in the USA
Boston Scientific has announced the US launch of DirectSense technology, a tool for monitoring the effect of radiofrequency (RF) energy delivery during cardiac ablation...
Same-day discharge “feasible for majority of AF ablation patients”
Same-day discharge after atrial fibrillation (AF) ablation is feasible for the majority of patients when a standardised protocol is used, findings of a multicentre cohort study, published in the Journal of the American...
CardioFocus submits HeartLight X3 PMA application to FDA
CardioFocus has submitted a pre-market approval (PMA) supplement to the US Food and Drug Administration (FDA) for the HeartLight X3 Endoscopic Ablation System for...
HRC 2019: Sequential approach using STAR mapping system identifies key early...
The use of a Stochastic Trajectory Analysis of Ranked signals (STAR) mapping approach consistently identified early sites of activation (ESA) in patients with persistent...
Mapping early sites of activation for AF can be used to...
A stochastic vector-based approach to mapping and ablation of atrial fibrillation (AF) can be used to determine early sites of activation and to guide...
High power short duration ablation for atrial fibrillation: Safety and effectiveness
As part of a session on novel mapping and ablation technologies of atrial fibrillation (AF) at the recent AF Symposium in Boston, USA (24–26...
New financing to commercialise Globe system for treatment of atrial fibrillation
In a new financing round, Kardium has raised an undisclosed amount to fund commercial activities in Europe and Canada, and for clinical testing of the Globe...
DIAMOND-AF paroxysmal study complete with first enrolment in DIAMOND-AF II persistent...
EPIX Therapeutics, a medical device company that designs and manufactures a catheter-based system for the treatment of patients with atrial fibrillation (AF), has announced...
Boston Scientific to acquire Cryterion Medical
As part of its plan to expand it atrial fibrillation ablation therapy offering, Boston Scientific Corporation has announced a definitive agreement to acquire Cryterion...
Real-time lesion formation and gap detection during ablation: DURABLE-I follow-up
One-year results from the Dielectric Unravveling of RAdiofrequency ABLation Effectiveness (DURABLE-I) clinical trial have shown that the KODEX (Navix International Limited) system help to...
Boston Scientific announces acquisition of Securus Medical Group
Boston Scientific have announced the acquisition of Securus Medical Group, a privately-held company that has developed a thermal monitoring system for the continuous measurement...
Successful ablation for ventricular tachycardia associated with markedly reduced mortality in...
Wendy Tzou (University of Colorado School of Medicine, Denver, USA) and colleagues at the International Ventricular Tachycardia Ablation Center Collaborative group (IVTCC) published two...
Biomarker predicts success of atrial fibrillation treatment
Written by Hannah Woolley, Cardiac Rhythm News Editor
Heart imaging has been successfully used to predict the benefit or futility of catheter ablation. The investigators...
Imaging-based simulations for predicting sudden death and guiding ablation
Natalia Trayanova envisions the future of cardiology and electrophysiology advancing through personalised medicine and computational simulations. Trayanova is the director of the Computational Cardiology...
Results of CASTLE-AF trial published: catheter ablation better than conventional drug...
The results of the CASTLE-AF study, published today in the New England Journal of Medicine, show that patients treated with radiofrequency catheter ablation rather than...
Less bleeding in ablation with interrupted dabigatran compared to uninterrupted warfarin
The results of ABRIDGE-J, a Japanese multicentre randomised study on minimally interrupted dabigatran vs. uninterrupted warfarin for catheter ablation, were presented during a late-breaking...
Imricor announces completion of enrolment for MRI-guided ablations clinical study
Imricor Medical Systems announced today the completion of enrolment for the clinical study to evaluate Imricor’s Vision-MR Ablation Catheter for the treatment of atrial flutter...
Five surprising messages from this year’s Europe AF
1.
The "ILL-CONCEIVED" pallas study may be relaunched
John Camm
"I want to say just a few quick words about dronedarone", John Camm (St George's University of...
Biosense Webster launches Carto 3 system Carto Visitag module with Ablation...
Biosense Webster has launched of the Carto Visitag module with Ablation Index, a new technology providing visual indication based on the integration of power,...
AF ablation associated with phrenic nerve injury: Is this complication now...
Phrenic nerve injury is a well-established complication of all types of atrial fibrillation (AF) ablation and is most common with balloon-based approaches, writes Hugh...
US FDA approves Abbott’s FlexAbility Catheter, Sensor Enabled
The FlexAbility Ablation Catheter, Sensor Enabled is designed to improve the versatility and precision during cardiac ablation procedures to treat atrial flutter.
The Sensor Enabled...
Superior vena cava does not seem to contribute to long-standing persistent...
The arrhythmogenicity of the superior vena cava has been rarely detected in patients with long-standing persistent atrial fibrillation, according to study from China recently...
CardioFocus HeartLight Excalibur balloon undergoes initial clinical evaluation
CardioFocus has announced the initial clinical evaluation of the HeartLight Excalibur balloon, a next-generation technology designed for the treatment of atrial fibrillation. The device...
Discover the latest evidence and ablation techniques for persistent AF treatment
Join atrial fibrillation (AF) experts Prof Richard Schilling (St Barts Hospital, London UK), Prof Carlo de Asmundis (Universitair Ziekenhuis, Brussels, Belgium) and PD Dr...
King’s College London joins with Cambridge Design Partnership to further develop...
Cambridge Design Partnership recently announced it is working with Kings College London to further develop a new steerable catheter designed to treat complex cardiac...
Biosense Webster announces US launch of ThermoCool SmartTouch SF catheter
Biosense Webster has announced the US launch of the ThermoCool SmartTouch SF catheter. According to a company release, the catheter pairs contact force technology...